College House 1.20
Sarah Price is a research fellow in Professor Hamilton’s Discovery Group, working in the field of cancer diagnostics. She joined the University of Exeter Medical School as a postgraduate student in 2013. After completing her PhD in early 2016, she worked for a short while as an impact fellow, developing an impact case study of Professor Willie Hamilton for the Research Excellence Framework due in 2021.
She was appointed a research fellow in July 2016 and is currently lead researcher for a project funded by Cancer Research UK. In this study, she is evaluating trends in the timeliness of cancer diagnosis, and the impact of the 2015 National Institute for Health and Care Excellence (NICE) Guidelines on the recognition and referral for suspected cancer.
Before joining University of Exeter Medical School, Sarah worked in the field of science, technology and medicine publishing, specializing in editorial and production roles.
- BSc (hons) Physiology (University of Manchester)
- PhD What are we missing by ignoring text records in the Clinical Practice Research Datalink? (University of Exeter)
Sarah has expertise in using large datasets of observational data, such as the Clinical Practice Research Datalink (CPRD) and National Cancer Registration Service data. She is interested in modelling and regression methods, and is developing her skills in survival analysis.
Sarah is also interested in whether pre-existing conditions complicate the presentation and interpretation of cancer symptoms, and whether cancer diagnosis is delayed in patients with multimorbidity.
Sarah works closely with other groups within University of Exeter, including health economics, and is developing research ideas in the area of cancer and multimorbidity with the Health Services & Policy Research Group.
Sarah’s PhD focused on bias in observational datasets associated with the standard practice of restricting analysis to coded fields of the medical record – ignoring information stored in text fields.
Her main interest is cancer diagnostics. She is currently lead researcher of a CRUK study evaluating trends in the timeliness of cancer diagnosis, i.e. time to diagnosis and stage at diagnosis. The study will examine the impact of the 2015 National Institute for Health and Care Excellence (NICE) Guidelines on the recognition and referral for suspected cancer.
She was co-applicant on a successful Health Technology Assessment Grant to assess the impact of cancer decision support tools implemented in GP IT software. This study, conducted jointly with Health Economics, will start in early 2017.
- CRUK Impact study. Evaluating trends in the timeliness (time to diagnosis, stage at diagnosis) of cancer diagnosis in the UK population for 22 cancer, and the impact of recently updated NICE guidelines for GPs on which patients should be referred for investigation for possible cancer
- HTA Study of the impact of cancer decision support tools in primary care
Grants / funding
- Understanding the effectiveness, cost-effectiveness and current use of cancer diagnostic tools to aid decision-making in primary care. Peters, J, Lewis, R, Neal, R, Spencer A, Price S, Hamilton, W, Cooper, C. HTA £240,800. 2017-8
Publications by category
Publications by year
- 2014–2015: Postgraduate representative on the Research Degrees Liaison Forum
- 2015–2016: Postgraduate representative on the University of Exeter Athena SWAN Working Group
- Reviewer for Family Practice